Skip to main content

Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.

Publication ,  Journal Article
Morrow, DA; Velazquez, EJ; DeVore, AD; Desai, AS; Duffy, CI; Ambrosy, AP; Gurmu, Y; McCague, K; Rocha, R; Braunwald, E
Published in: Circulation
May 7, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 7, 2019

Volume

139

Issue

19

Start / End Page

2285 / 2288

Location

United States

Related Subject Headings

  • Valsartan
  • Treatment Outcome
  • Tetrazoles
  • Survival Analysis
  • Risk
  • Natriuretic Peptide, Brain
  • Middle Aged
  • Male
  • Humans
  • Hospitalization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morrow, D. A., Velazquez, E. J., DeVore, A. D., Desai, A. S., Duffy, C. I., Ambrosy, A. P., … Braunwald, E. (2019). Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation, 139(19), 2285–2288. https://doi.org/10.1161/CIRCULATIONAHA.118.039331
Morrow, David A., Eric J. Velazquez, Adam D. DeVore, Akshay S. Desai, Carol I. Duffy, Andrew P. Ambrosy, Yared Gurmu, Kevin McCague, Ricardo Rocha, and Eugene Braunwald. “Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.Circulation 139, no. 19 (May 7, 2019): 2285–88. https://doi.org/10.1161/CIRCULATIONAHA.118.039331.
Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, et al. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation. 2019 May 7;139(19):2285–8.
Morrow, David A., et al. “Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.Circulation, vol. 139, no. 19, May 2019, pp. 2285–88. Pubmed, doi:10.1161/CIRCULATIONAHA.118.039331.
Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation. 2019 May 7;139(19):2285–2288.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 7, 2019

Volume

139

Issue

19

Start / End Page

2285 / 2288

Location

United States

Related Subject Headings

  • Valsartan
  • Treatment Outcome
  • Tetrazoles
  • Survival Analysis
  • Risk
  • Natriuretic Peptide, Brain
  • Middle Aged
  • Male
  • Humans
  • Hospitalization